Literature DB >> 1329591

Abnormal lung function in polyurethane foam producers. Weak relationship to toluene diisocyanate exposures.

R N Jones1, R J Rando, H W Glindmeyer, T A Foster, J M Hughes, C E O'Neil, H Weill.   

Abstract

Exposures to toluene diisocyanate (TDI) were studied for effects on respiratory health of workers in two plants manufacturing polyurethane foams. Intensive personal monitoring was used to characterize job exposures. Of 4,845 12-min personal samples, 9% exceeded 5 ppb and 1% exceeded 20 ppb. Initial questionnaire and spirometry were obtained in 386 workers (88.7% of target population). Current smoking was associated with lower mean FEV1 and FEF25-75, but percent predicted (% pred) means were normal in all smoking categories. Multiple regression showed significant adverse effects of cumulative TDI exposure on initial level of FVC and FEV1 of current smokers, and an effect at borderline significance (p less than 0.063) on FEF25-75 over all smoking categories. Logistic regression showed that chronic bronchitis was more prevalent among those with higher cumulative exposures, after controlling for smoking, age, and sex. Methacholine (MCh) reactivity was associated with reduced airway function, -8.5% pred for FEV1 and -20.0% pred for FEF25-75. In 227 with adequate follow-up, the slopes of annual change were abnormal, for example, FEV1 of -67 ml/yr in current and -53 ml/yr in never smokers. Men had worse FEV1 declines than did women, -71 ml/yr versus -43 ml/yr. TDI exposure, lifetime or concurrent, had no significant effect on slopes, despite its demonstrated effects on initial level of lung function and on prevalence of chronic bronchitis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1329591     DOI: 10.1164/ajrccm/146.4.871

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  8 in total

1.  Respiratory symptoms, sensitization, and exposure response relationships in spray painters exposed to isocyanates.

Authors:  Anjoeka Pronk; Liesbeth Preller; Monika Raulf-Heimsoth; Irene C L Jonkers; Jan-Willem Lammers; Inge M Wouters; Gert Doekes; Adam V Wisnewski; Dick Heederik
Journal:  Am J Respir Crit Care Med       Date:  2007-07-26       Impact factor: 21.405

2.  Response to Goodman et al.

Authors:  Lynne E Pinkerton; James H Yiin; Robert D Daniels; Kenneth W Fent
Journal:  Am J Ind Med       Date:  2017-02       Impact factor: 2.214

3.  Respiratory health surveillance in a toluene di-isocyanate production unit, 1967-97: clinical observations and lung function analyses.

Authors:  M G Ott; J E Klees; S L Poche
Journal:  Occup Environ Med       Date:  2000-01       Impact factor: 4.402

Review 4.  Respiratory and other hazards of isocyanates.

Authors:  X Baur; W Marek; J Ammon; A B Czuppon; B Marczynski; M Raulf-Heimsoth; H Roemmelt; G Fruhmann
Journal:  Int Arch Occup Environ Health       Date:  1994       Impact factor: 3.015

Review 5.  Occupational asthma risk from exposures to toluene diisocyanate: A review and risk assessment.

Authors:  Robert D Daniels
Journal:  Am J Ind Med       Date:  2018-02-01       Impact factor: 2.214

6.  Incidence of Occupational Asthma and Exposure to Toluene Diisocyanate in the United States Toluene Diisocyanate Production Industry.

Authors:  James J Collins; Steve Anteau; Patrick R Conner; Laura D Cassidy; Brent Doney; Mei Lin Wang; Laura Kurth; Michael Carson; Don Molenaar; Carrie A Redlich; Eileen Storey
Journal:  J Occup Environ Med       Date:  2017-12       Impact factor: 2.162

7.  Author's Response to Letters to the Editor regarding "Risk Assessment for Toluene Diisocyanate and Respiratory Disease Human Studies".

Authors:  Robert M Park
Journal:  Saf Health Work       Date:  2022-01-19

8.  Risk Assessment for Toluene Diisocyanate and Respiratory Disease Human Studies.

Authors:  Robert M Park
Journal:  Saf Health Work       Date:  2020-12-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.